Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women's midlife health.

IF 3.9 4区 医学 Q1 OBSTETRICS & GYNECOLOGY
Climacteric Pub Date : 2026-04-01 Epub Date: 2026-01-07 DOI:10.1080/13697137.2025.2584061
Alison Maunder, Amelia K Mardon, Vibhuti Rao, Sophia Torkel, Najwa-Joelle Metri, Jing Liu, Guoyan Yang, Nora Giese, Evangeline Mantzioris, Nur K Abdul Jafar, Geovanna E Rodrigues de Souza, Ieman Al-Kanini, Lorena Romero, Nick Panay, Hugo Pedder, Carolyn Ee
{"title":"Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women's midlife health.","authors":"Alison Maunder, Amelia K Mardon, Vibhuti Rao, Sophia Torkel, Najwa-Joelle Metri, Jing Liu, Guoyan Yang, Nora Giese, Evangeline Mantzioris, Nur K Abdul Jafar, Geovanna E Rodrigues de Souza, Ieman Al-Kanini, Lorena Romero, Nick Panay, Hugo Pedder, Carolyn Ee","doi":"10.1080/13697137.2025.2584061","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Menopausal hormone therapy is standard treatment, but some women use complementary therapies. This review examines complementary therapies for menopause to inform International Menopause Society (IMS) recommendations.</p><p><strong>Method: </strong>A systematic search of six databases (January 2022-December 2024) identified randomized controlled trials (RCTs) and systematic reviews on complementary therapies for menopause. Outcomes included menopausal, vasomotor, genitourinary, cardiometabolic, sleep symptoms, bone health and safety. The study quality and certainty of evidence were evaluated using Cochrane Risk of Bias (RoB2), A MeaSurement Tool to Assess Systematic Reviews (AMSTAR 2) and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE).</p><p><strong>Results: </strong>From 3187 citations, 158 studies were included: one overview, 36 meta-analyses, seven systematic reviews and 114 RCTs. While promising evidence was found for acupuncture, Chinese herbal medicine (CHM), herbs, nutrients, mind-body/touch therapies for a variety of symptoms, most was of low/very low certainty. High-certainty evidence supports vitamin D safety; and moderate-certainty evidence supports black cohosh (vasomotor/menopausal symptoms), CHM (menopausal symptoms, sleep, blood pressure), acupuncture + CHM (sleep) and vitamin D (fracture risk). Most complementary therapies are safe.</p><p><strong>Conclusion: </strong>Vitamin D, black cohosh, CHM and acupuncture + CHM may improve some menopausal symptoms, but overall evidence remains limited. More rigorous research is needed on the efficacy and safety of complementary therapies for menopause.</p>","PeriodicalId":10213,"journal":{"name":"Climacteric","volume":" ","pages":"165-209"},"PeriodicalIF":3.9000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Climacteric","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13697137.2025.2584061","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Menopausal hormone therapy is standard treatment, but some women use complementary therapies. This review examines complementary therapies for menopause to inform International Menopause Society (IMS) recommendations.

Method: A systematic search of six databases (January 2022-December 2024) identified randomized controlled trials (RCTs) and systematic reviews on complementary therapies for menopause. Outcomes included menopausal, vasomotor, genitourinary, cardiometabolic, sleep symptoms, bone health and safety. The study quality and certainty of evidence were evaluated using Cochrane Risk of Bias (RoB2), A MeaSurement Tool to Assess Systematic Reviews (AMSTAR 2) and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE).

Results: From 3187 citations, 158 studies were included: one overview, 36 meta-analyses, seven systematic reviews and 114 RCTs. While promising evidence was found for acupuncture, Chinese herbal medicine (CHM), herbs, nutrients, mind-body/touch therapies for a variety of symptoms, most was of low/very low certainty. High-certainty evidence supports vitamin D safety; and moderate-certainty evidence supports black cohosh (vasomotor/menopausal symptoms), CHM (menopausal symptoms, sleep, blood pressure), acupuncture + CHM (sleep) and vitamin D (fracture risk). Most complementary therapies are safe.

Conclusion: Vitamin D, black cohosh, CHM and acupuncture + CHM may improve some menopausal symptoms, but overall evidence remains limited. More rigorous research is needed on the efficacy and safety of complementary therapies for menopause.

管理更年期症状的补充疗法:国际更年期协会关于妇女中年健康建议更新的系统综述
目的:更年期激素治疗是标准治疗,但一些妇女使用补充治疗。这篇综述探讨了更年期的补充疗法,以告知国际更年期学会(IMS)的建议。方法:系统检索6个数据库(2022年1月- 2024年12月),确定绝经期补充疗法的随机对照试验(rct)和系统综述。结果包括绝经期、血管舒缩、泌尿生殖系统、心脏代谢、睡眠症状、骨骼健康和安全。采用Cochrane偏倚风险(RoB2)、评估系统评价的测量工具(AMSTAR 2)和推荐、评估、发展和评价分级(GRADE)对研究质量和证据的确定性进行评价。结果:从3187个引用中,纳入158项研究:1项综述,36项荟萃分析,7项系统综述和114项随机对照试验。虽然在针灸、中草药、草药、营养、身心/触觉治疗各种症状方面发现了有希望的证据,但大多数证据的确定性都很低/非常低。高确定性证据支持维生素D的安全性;中等确定性证据支持黑升麻(血管舒缩/更年期症状)、CHM(更年期症状、睡眠、血压)、针灸+ CHM(睡眠)和维生素D(骨折风险)。大多数补充疗法都是安全的。结论:维生素D、黑升麻、中药、针刺+中药可改善部分更年期症状,但总体证据有限。需要对更年期补充疗法的有效性和安全性进行更严格的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Climacteric
Climacteric 医学-妇产科学
CiteScore
1.70
自引率
7.10%
发文量
53
审稿时长
1 months
期刊介绍: Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women. Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments. The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书